Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Pediatric Blood & Cancer
|
February 8, 2014
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma
Johnnie K Bass, Jie Huang, Arzu Onar-Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2018
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill, Maura Massimino, Eric Bouffet, et al.
JAMA Oncology
|
October 17, 2024
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial
Nathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, et al.
Frontiers in Oncology
|
May 1, 2023
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience
Sarah M Trinder, Campbell McKay, Phoebe Power, et al.
Neuro-Oncology
|
December 19, 2024
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial
Karsten Nysom, Lindsay B Kilburn, Sarah E S Leary, et al.
The Journal of Molecular Diagnostics : JMD
|
July 30, 2023
Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study
Christine L White, Kathryn M Kinross, Molly K Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.
Nature Medicine
|
November 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford, et al.
Genome Medicine
|
April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Chelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Nature Medicine
|
June 6, 2024
Precision-guided treatment in high-risk pediatric cancers
Loretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Pediatric Blood & Cancer
|
February 8, 2014
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma
Johnnie K Bass, Jie Huang, Arzu Onar-Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2018
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill, Maura Massimino, Eric Bouffet, et al.
JAMA Oncology
|
October 17, 2024
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial
Nathalie Gaspar, Giun-Yi Hung, Sandra J Strauss, et al.
Frontiers in Oncology
|
May 1, 2023
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience
Sarah M Trinder, Campbell McKay, Phoebe Power, et al.
Neuro-Oncology
|
December 19, 2024
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial
Karsten Nysom, Lindsay B Kilburn, Sarah E S Leary, et al.
The Journal of Molecular Diagnostics : JMD
|
July 30, 2023
Implementation of DNA Methylation Array Profiling in Pediatric Central Nervous System Tumors: The AIM BRAIN Project: An Australian and New Zealand Children's Haematology/Oncology Group Study
Christine L White, Kathryn M Kinross, Molly K Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.
Nature Medicine
|
November 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford, et al.
Genome Medicine
|
April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
Chelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Nature Medicine
|
June 6, 2024
Precision-guided treatment in high-risk pediatric cancers
Loretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Page
of 4